Omega-3 and ranibizumab for age-related macular degeneration: A systematic review protocol

BACKGROUND: Omega-3 and ranibizumab (O3R) has been reported to treat age-related macular degeneration (ARMD) effectively. However, up to the present, no systematic review specifically addressed the efficacy of O3R for the treatment of ARMD. Therefore, in this study, we will propose to assess the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Yan, Liu, Hong-wei, Sun, Peng, Zhou, Ping-ping, Wang, Jian-jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455935/
https://www.ncbi.nlm.nih.gov/pubmed/30921177
http://dx.doi.org/10.1097/MD.0000000000014516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455935/
https://www.ncbi.nlm.nih.gov/pubmed/30921177
http://dx.doi.org/10.1097/MD.0000000000014516

Ejemplares similares